Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > Nutrell is another BILLION $$$$ project
View:
Post by Hiddensecrets on Feb 02, 2021 11:10am

Nutrell is another BILLION $$$$ project

Anyone who wants to stay in business and encourage clients to return will be using this Nutrell product.   I am considering using it for my own clients whom come to the office.    And I can use it at home as often my son has many friends and home can get contaminated. 

Product retails for $ 34 per bottle.    

Obtaining just 1% of USA market:   3,300,000 persons * $ 34 per bottle = $ 112 million in revenue.   

If they use several bottles per year, say like a business does, then you have a business generating between $ 500 million and $ 1 billion per year in revenue, with FAT PROFIT MARGINS.

Our cost of 12 million shares or $ 6 million when converted to $$$ is peanuts versus the potential $$$ in revenue.

It is no longer a question of whether, but when do we become a BILLION $$$ company.

PLUS:  sellers will probably hold on to their shares as they see the appreciation in price coming in the future.  They are not stupid.   Why settle for 55 cents when you can get $ 5.50 in short order. 

Our CEO is aiming at sales of $ 1.9 BILLION per year. 

https://cbmrusa.com/

MPO
Comment by Jasper66 on Feb 02, 2021 11:48am
Is this product already being sold? If so where?
Comment by Heroica on Feb 02, 2021 1:22pm
Cbmrusa.com
Comment by Jasper66 on Feb 02, 2021 1:29pm
Thanks for the site link. Great to see, the product is being sold already, Medivolve will start making money from it as soon as the transaction is completed.
Comment by Jasper66 on Feb 02, 2021 1:46pm
https://nuturell.com/
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities